Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma

Area of Science:

• Neuroscience
• Oncology
• Cell Biology

Background:

• Microtubule-associated protein Tau is extensively studied for microtubule assembly.
• Emerging evidence suggests Tau interacts with cancer-related protein kinases, implicating it in oncogenesis.
• The role of Tau in glioblastoma pathogenesis is largely unexplored.

Purpose of the Study:

• To review the literature linking Tau protein to cancer.
• To focus on the mechanistic role of Tau in oncogenic processes.
• To investigate Tau's involvement in glioblastoma and explore therapeutic targeting strategies.

Main Methods:

• Literature review and synthesis of existing research data.
• Mechanistic analysis of Tau's role in oncogenic pathways.
• Focus on glioblastoma as a model for Tau-related cancer pathology.

Main Results:

• Tau's interaction with protein kinases suggests a role beyond microtubule dynamics.
• Tau influences microtubule-independent pathways crucial for cancer development.
• Pathological significance of Tau in glioblastoma warrants further investigation.

Conclusions:

• Tau protein represents a potential therapeutic target for cancer, especially glioblastoma.
• Understanding Tau's interaction with kinases is key to developing novel anti-cancer therapies.
• Targeting Tau may offer a new strategy for treating glioblastoma.